Alexandre Becker/LinkedIn
May 15, 2026, 15:46
Alexandre Becker: Clinical Importance of Neonatal Thrombocytopenia in Newborns
Alexandre Becker, Professor of Postgraduate Studies in Clinical Hematology, Hemotherapy, and Quality Management and Control at ULBRA, shared a post on LinkedIn:
”Neonatal Thrombocytopenia
Neonatal thrombocytopenia is a common condition in neonatal intensive care units (15–40percent of infants), serving as a crucial marker of severe diseases such as sepsis, viral infection, necrotizing enterocolitis, or alloimmunization.
Its importance lies in the high risk of bleeding (including intracranial hemorrhage) and the need for rapid diagnosis to differentiate treatable causes and prevent serious sequelae or death.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Sep 29, 2026, 22:45Victor Agunyego: Paracetamol – The Most Common Drug We Underestimate
-
Sep 29, 2026, 22:42Nova Sinclair: Advancing the Future of Hematology – Meet Our 2027 Organizing Committee
-
Sep 29, 2026, 22:41Lorenz Räber: Intracoronary Imaging in PCI – Why, When, How, and Which Modality?
-
Sep 29, 2026, 22:31Selma Turkovic: Pleased to Deliver the Opening Presentation at Kingston Hospital
-
Sep 29, 2026, 22:31Miguel Teran: Ultrasound and Simulation in Arterial Blood Sampling
-
Sep 29, 2026, 21:47Javed Anees: DADA2 – When a Young Stroke Is More Than a Stroke
-
Sep 29, 2026, 22:28Mohammad Refaei: Navigating Your Career in Hematology From Training to Practice
-
Sep 29, 2026, 22:27Matteo Foschi: 10 Clinical Pearls for Antithrombotic Therapy in Secondary Stroke Prevention
-
Sep 29, 2026, 22:26A Global Call for Action on Cardiovascular Health on World Heart Day – ISTH